Preclinical development of 2ND generation HIV maturation inhibitors
Ended Project Grant Awarded Last action
- Award ID
- R41GM132683
- Recipient
-
DFH Pharma, Inc. UEI ZS2FYG92ALX3
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $171,475
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- Gaithersburg, MD 20886, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $171,475 |
Quick answers
Who received award R41GM132683?
R41GM132683 was awarded to DFH Pharma, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on September 1, 2018.
How much is award R41GM132683 worth?
$171,475 has been obligated on R41GM132683.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award